Naguy Ahmed, Elbadry Hytham, Salem Hossam
Private Practice Psychiatrist, Alexandria, Egypt.
Consultant Psychiatrist, General Organization for Teaching Hospitals and Institutes, Cairo, Egypt.
J Family Med Prim Care. 2020 Aug 25;9(8):4009-4015. doi: 10.4103/jfmpc.jfmpc_12_20. eCollection 2020 Aug.
Suicide remains a psychiatric emergency, tragedy, a public health burden, and for those aged 15-29, is the second leading cause of death globally. Stigma attached to psychiatric disorders and suicide means many people feel unable to seek help.
We highlighted confusing nosology, psychopathology, neurobiological underpinnings, typology, and, risk factor pertinent to suicide. A road-map to the clinical assessment and management of suicide has also been provided. Last, but not least, we tried to dispel the long-held myths about suicide.
EMBASE, Ovid MEDLINE, PubMed, Scopus, Web of Science, and Cochrane Database of Systemic Reviews were searched for all relevant studies up to date of Jan, 2020.
Suicide is self-inflicted death with evidence (explicit/implicit) of intention to die. Suicide reflects many disparate determinants release/relief, response-to the disordered thinking, religious, revenge, rebirth, reunification or rational. 5-HT deficiency appears central to the neurobiology of suicide. Durkheim proposed 4 types of suicide (egoistic, altruistic, anomic, fatalistic). Risk factors for suicide entail both static and dynamic factors. Dynamic factors encompass both clinical and situational variables. Shneidman's concepts of perturbation and psychache are very crucial to consider when assessing the risk. Suicide rating scales are only ancillary with the Modified high-risk construct scale balances vectors of suicidality versus survivality. Myths germane to suicide abound that need to be demystified. Psychiatric management capitalizes on determining a setting for treatment and supervision, attending to patient's safety, as well as working to establish a cooperative and collaborative physician-patient relationship. This entails both psychosocial 'package' and somatic treatments and the best outcomes mandate well-keeled combined approaches. Pharmacologic interventions aim chiefly at acute symptomatic relief. Recently, heaps of data accrue speaking to the idea of ground-breaking 'anti-suicidal' agents that might alleviate suicidal ideation (SI).
Suicide continues to be a complex public health problem of global calibre. It is variably tied to a myriad of risk factors underscoring likely etiological heterogeneity. That said, suicides can, at least partially, be prevented by restricting access to means of suicide, by training primary care physicians and health workers to identify people at risk as well as to assess and manage respective crises, provide adequate follow-up care and address the way this is portrayed in the media. A host of psychotherapeutic, pharmacological, or neuromodulatory treatments of mental disorders are readily available that can alter this acrimonious trajectory.
自杀仍然是一种精神科急症、悲剧、公共卫生负担,对于15至29岁的人群而言,是全球第二大死因。与精神疾病和自杀相关的污名意味着许多人觉得无法寻求帮助。
我们强调了与自杀相关的令人困惑的疾病分类学、精神病理学、神经生物学基础、类型学以及风险因素。还提供了一份自杀临床评估与管理的路线图。最后但同样重要的是,我们试图消除长期以来关于自杀的误解。
检索了EMBASE、Ovid MEDLINE、PubMed、Scopus、Web of Science和Cochrane系统评价数据库,以查找截至2020年1月的所有相关研究。
自杀是自我造成的死亡,并有(明确/隐含)死亡意图的证据。自杀反映了许多不同的决定因素,如解脱/缓解、对紊乱思维的反应、宗教、复仇重生、团聚或理性。5-羟色胺缺乏似乎是自杀神经生物学的核心。涂尔干提出了4种自杀类型(利己型、利他型、失范型、宿命型)。自杀的风险因素包括静态和动态因素。动态因素包括临床和情境变量。在评估风险时,施奈德曼的扰动和心理痛苦概念非常关键。自杀评定量表只是辅助工具,而改良的高风险构建量表平衡了自杀倾向与生存倾向的向量。与自杀相关的误解比比皆是,需要消除。精神科管理的重点在于确定治疗和监督的环境、关注患者安全以及努力建立合作性的医患关系。这需要心理社会“套餐”和躯体治疗,而最佳结果需要良好平衡的综合方法。药物干预主要旨在实现急性症状缓解。最近,大量数据积累支持了可能减轻自杀观念(SI)的突破性“抗自杀”药物的观点。
自杀仍然是一个具有全球影响力的复杂公共卫生问题。它与众多风险因素存在不同程度的关联,突出了可能的病因异质性。也就是说,至少可以通过限制自杀手段的获取、培训初级保健医生和卫生工作者识别有风险的人以及评估和管理各自的危机、提供充分的后续护理以及处理媒体对此的报道方式来部分预防自杀。有许多针对精神障碍的心理治疗、药物治疗或神经调节治疗方法可供使用,这些方法可以改变这种严峻的趋势。